US Broker Ratings

Novo Nordisk A/S (NVO) Stock Analysis: A Healthcare Giant with a 71.4% Return on Equity

Investors looking for a robust player in the healthcare sector might find Novo Nordisk A/S (NYSE: NVO) a compelling option. With its headquarters in Bagsvaerd, Denmark,..

Cencora, Inc. (COR) Stock Analysis: Robust Growth Potential with a 14.56% Upside

Cencora, Inc. (NYSE: COR), a stalwart in the healthcare sector, is capturing investor attention with its promising growth trajectory and compelling stock potential. Headquartered in Conshohocken,..

DaVita Inc. (DVA) Stock Analysis: Navigating a 52-Week High with Cautious Optimism

DaVita Inc. (NYSE: DVA), a leader in the healthcare sector specializing in kidney dialysis services, has recently marked a significant milestone by reaching its 52-week high,..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: A Deep Dive into a 26.55% Potential Upside

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) stands as a compelling opportunity for investors within the dynamic healthcare sector, specifically in the niche of drug manufacturers focusing on..

Gilead Sciences, Inc. (GILD) Stock Analysis: Solid Growth with a 20.69% Upside Potential

Gilead Sciences, Inc. (NASDAQ: GILD) stands as a formidable player in the healthcare sector, specifically within the drug manufacturing industry. With a market capitalization of $161.66..

Stryker Corporation (SYK) Stock Analysis: Exploring Growth Potential and Analyst Confidence in the Healthcare Giant

Stryker Corporation (NYSE: SYK) remains a formidable player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $124.86 billion, Stryker’s..

Revvity, Inc. (RVTY) Stock Report: Analyzing the Healthcare Giant’s 4.10% Potential Upside

Revvity, Inc. (NYSE: RVTY), a prominent player in the healthcare sector, specifically in the diagnostics and research industry, is catching the eyes of investors with its..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Exploring a 17.68% Potential Upside

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a formidable player in the global healthcare sector, continues to capture the attention of individual investors. With a market capitalization..

Abbott Laboratories (ABT) Stock Analysis: Navigating a 12% Upside Potential Amid Robust Healthcare Offerings

Abbott Laboratories (NYSE: ABT), a cornerstone of the healthcare sector, continues to draw investor attention with its expansive portfolio and strategic positioning in the medical devices..

Corcept Therapeutics (CORT): A Biotech Powerhouse with 18% Upside Potential

Corcept Therapeutics Incorporated (NASDAQ: CORT), a prominent player in the biotechnology sector, has captured investor attention with its remarkable potential for growth and innovation. With a..

Tenet Healthcare Corporation (THC) Stock Analysis: Evaluating a Strong 8.91% Potential Upside

With a market capitalization of $20.51 billion, Tenet Healthcare Corporation (NYSE: THC) stands as a formidable player in the healthcare sector, specializing in medical care facilities..

Masimo Corporation (MASI) Stock Analysis: Stable Growth with a 24.99% Return on Equity

Investors considering opportunities in the healthcare sector should not overlook Masimo Corporation (NASDAQ: MASI), a key player in the medical devices industry. Known for its innovative..

Roivant Sciences Ltd. (ROIV) Stock Analysis: A Biotech Powerhouse with a 14.74% Potential Upside

Roivant Sciences Ltd. (NASDAQ: ROIV) has been capturing the attention of biotech investors, and for good reason. The United Kingdom-based biopharmaceutical company focuses on the development..

Labcorp Holdings Inc. (LH) Stock Analysis: Exploring the 7.52% Upside Potential and Strong Buy Ratings

Labcorp Holdings Inc. (NYSE: LH), a prominent player in the healthcare sector, operates within the Diagnostics & Research industry, offering a comprehensive suite of laboratory services...

Cigna Group (CI) Stock Analysis: Exploring a Potential 23% Upside in the Healthcare Sector

The Cigna Group (NYSE: CI), a prominent player in the healthcare plans industry, presents an intriguing opportunity for investors seeking long-term growth and stability. With a..

Humana Inc. (HUM) Stock Analysis: Evaluating Healthcare Growth with a 12% Upside Potential

Humana Inc. (NYSE: HUM), a stalwart in the healthcare sector, is capturing investor attention with its robust market presence and the potential for a 12.08% upside,..

Insulet Corporation (PODD) Stock Analysis: Eyeing a 42% Upside with Robust Revenue Growth

Insulet Corporation (NASDAQ: PODD) stands out in the healthcare sector with its innovative insulin delivery systems that have captured the attention of investors and analysts alike...

Ascendis Pharma A/S (ASND) Stock Analysis: Unveiling a 26% Upside Potential

Ascendis Pharma A/S (NASDAQ: ASND) is making waves in the biotechnology sector with its innovative approach to addressing unmet medical needs through TransCon-based therapies. With a..

BeOne Medicines Ltd. (ONC): Investor Outlook on a Biotechnology Powerhouse with a 31.53% Upside Potential

BeOne Medicines Ltd. (ONC), headquartered in Basel, Switzerland, is capturing investor attention with its robust pipeline of oncology treatments and an impressive potential upside of 31.53%...

GSK plc (GSK) Stock Analysis: Evaluating a 12.36% Potential Upside in the Healthcare Sector

GSK plc (GSK) stands as a formidable player in the healthcare sector, with its roots tracing back to 1715. Headquartered in London, this British multinational pharmaceutical..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds